Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of 5-[5-cyano-1-(pyridin-2-ylmethyl)-1H-indole-3-carboxamido] thiazole-4-carboxylic acid as a promising dual inhibitor of urate transporter 1 and xanthine oxidase
Fengwei Lin, Ming Sun, Jun Gao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115532-115532
Closed Access | Times Cited: 9

Showing 9 citing articles:

Recent Progress and Future Perspectives on Anti-Hyperuricemic Agents
Zhiqiang Sun, Xuewen Zhang, Zean Zhao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 19966-19987
Closed Access | Times Cited: 7
Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia
Fengxin Zheng, Suiqing Mai, Xiaolin Cen, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107381-107381
Closed Access | Times Cited: 6
Heterocyclic compounds as xanthine oxidase inhibitors for the management of hyperuricemia: synthetic strategies, structure–activity relationship and molecular docking studies (2018–2024)
Arshdeep Singh, Rabin Debnath, Viney Chawla, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 6, pp. 1849-1876
Closed Access | Times Cited: 5
Research progress and perspectives of dual-target inhibitors
Xiaojing Pang, Wenyan Xu, Jing Liang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117453-117453
Closed Access
Design, synthesis and biological evaluation of 2-[1-(pyridin-2-ylmethyl)-1H-pyrazole-3-carboxamido]benzoic acids as promising urate transporter 1 inhibitors with potential nephroprotective efficacy for the treatment of hyperuricemic nephropathy
Qing Mao, Peng Zhang, Fengwei Lin, et al.
European Journal of Medicinal Chemistry (2025) Vol. 290, pp. 117507-117507
Closed Access
Discovery of a Potent and Orally Bioavailable Xanthine Oxidase/Urate Transporter 1 Dual Inhibitor as a Potential Treatment for Hyperuricemia and Gout
Xinye Yang, Yong Li, Shengqiang Pan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 14668-14691
Closed Access | Times Cited: 2
Proline-derived quinoline formamide compounds as human urate transporter 1 inhibitors with potent uric acid-lowering activities
Shengnan Li, Hui Liao, Lijun Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116327-116327
Closed Access | Times Cited: 1
Indoles as promising Therapeutics: A review of recent drug discovery efforts
Naik Jui Pravin, Rohini S. Kavalapure, Shankar G. Alegaon, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108092-108092
Closed Access | Times Cited: 1
Dual inhibition strategy addressing hyperuricemia and oxidative stress: design, biological evaluation and stability studies of febuxostat-probenecid mutual prodrug
Aya Y. Rashad, Hoda G. Daabees, Mohamed Elagawany, et al.
Medicinal Chemistry Research (2024)
Closed Access
Page 1

Scroll to top